01964nas a2200457   4500000000100000008004100001260000900042653001500051653001000066653001800076653003100094653001000125653002100135653001600156653001100172653002300183653001000206653001100216653001100227653002000238653001200258653000900270653001600279653001200295653003000307100001100337700001600348700001300364700001400377700001300391700001400404700001100418700001600429700001100445700001400456245009400470300001000564490000600574520091200580022001401492       1992                            d  c199210aAdolescent10aAdult10aCD4-CD8 Ratio10aCD4-Positive T-Lymphocytes10aChild10aChild, Preschool10aComorbidity10aFemale10aHIV Seroprevalence10aHIV-210aHumans10aInfant10aInfant, Newborn10aleprosy10aMale10aMiddle Aged10aSenegal10aSeroepidemiologic Studies1 aBlum L1 aOgougbemy M1 aM'Boup S1 aGrimaud J1 aMillan J1 aLaunois P1 aGaye Y1 aLe Guenno B1 aGaye A1 aFlageul B00a[Epidemiological study of HIV seroprevalence in a leprosy patient population in Senegal].  a35-410 v83 a<p>We report the findings of an epidemiological study conducted between June 1989 and February 1990 on a population of leprosy patients in southern Senegal (Bignona major endemic disease sector). Two types of population were studied: patients living in urban areas and inmates of leprosaria. The global HIV seroprevalence (HIV 2 in all cases) of the leprosy-patient population was 1.15% (3/257): 0.8% (1/130) for the urban group and 1.5% (2/127) for the leprosaria. The seroprevalence rate does not differ significantly from that for the control group studied and for blood donors (1/221). The diagnosis of leprosy in the seropositive subjects had been established before 1980. None of them showed any sign of relapse. The immunodepression associated with the presence of HIV was only moderate: it was reflected in a lowering of the CD4 count and of the CD4/CD8 ratio, but with no clinical sign of AIDS.</p>  a0001-5938